Steenbrugge, J., Elst, N. V., Demeyere, K., Wever, O. D., Sanders, N. N., Broeck, W. V. D., . . . Meyer, E. (2021). OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer. Nature Portfolio.
Style de citation Chicago (17e éd.)Steenbrugge, Jonas, Niels Vander Elst, Kristel Demeyere, Olivier De Wever, Niek N. Sanders, Wim Van Den Broeck, Eric Ciamporcero, Timothy Perera, et Evelyne Meyer. OMO-1 Reduces Progression and Enhances Cisplatin Efficacy in a 4T1-based Non-c-MET Addicted Intraductal Mouse Model for Triple-negative Breast Cancer. Nature Portfolio, 2021.
Style de citation MLA (8e éd.)Steenbrugge, Jonas, et al. OMO-1 Reduces Progression and Enhances Cisplatin Efficacy in a 4T1-based Non-c-MET Addicted Intraductal Mouse Model for Triple-negative Breast Cancer. Nature Portfolio, 2021.